This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2003 Dec 16;108(24):2950-3.

doi: 10.1161/01.CIR.0000109205.35813.8E.

Should B-type natriuretic peptide be measured routinely to guide the diagnosis and management of chronic heart failure?

Milton Packer¹

Affiliations

Affiliation

¹ Division of Circulatory Physiology, Columbia University, College of Physicians and Surgeons, 630 West 168th Street, New York, NY 10032, USA. mp65@Columbia.edu

PMID: 14676134
DOI: 10.1161/01.CIR.0000109205.35813.8E

Editorial

Should B-type natriuretic peptide be measured routinely to guide the diagnosis and management of chronic heart failure?

Milton Packer. Circulation. 2003.

. 2003 Dec 16;108(24):2950-3.

doi: 10.1161/01.CIR.0000109205.35813.8E.

Author

Milton Packer¹

Affiliation

¹ Division of Circulatory Physiology, Columbia University, College of Physicians and Surgeons, 630 West 168th Street, New York, NY 10032, USA. mp65@Columbia.edu

PMID: 14676134
DOI: 10.1161/01.CIR.0000109205.35813.8E

No abstract available

PubMed Disclaimer

Comment in

Routine measurement of natriuretic peptide to guide the diagnosis and management of chronic heart failure.
Januzzi JL, Maisel AS. Januzzi JL, et al. Circulation. 2004 Jun 29;109(25):e325-6; author reply e325-6. doi: 10.1161/01.CIR.0000132585.12965.D6. Circulation. 2004. PMID: 15226236 No abstract available.
Routine measurement of natriuretic peptide to guide the diagnosis and management of chronic heart failure.
Troughton RW, Richards AM, Yandle TG, Nicholls G. Troughton RW, et al. Circulation. 2004 Jun 29;109(25):e325-6; author reply e325-6. Circulation. 2004. PMID: 15232832 No abstract available.
Routine measurement of natriuretic peptide to guide the diagnosis and management of chronic heart failure.
Nishikimi T, Matsuoka H. Nishikimi T, et al. Circulation. 2004 Jun 29;109(25):e325-6; author reply e325-6. Circulation. 2004. PMID: 15232833 No abstract available.

Comment on

Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure.
Tang WH, Girod JP, Lee MJ, Starling RC, Young JB, Van Lente F, Francis GS. Tang WH, et al. Circulation. 2003 Dec 16;108(24):2964-6. doi: 10.1161/01.CIR.0000106903.98196.B6. Epub 2003 Dec 8. Circulation. 2003. PMID: 14662703

Similar articles

The natriuretic peptides in heart failure.
Richards AM. Richards AM. Basic Res Cardiol. 2004 Mar;99(2):94-100. doi: 10.1007/s00395-004-0461-z. Epub 2004 Jan 23. Basic Res Cardiol. 2004. PMID: 14963668 Review.
Brain natriuretic peptide: clinical and research challenges.
Carrillo-Jimenez R, Borzak S, Hennekens CH. Carrillo-Jimenez R, et al. J Cardiovasc Pharmacol Ther. 2007 Jun;12(2):85-8. doi: 10.1177/1074248407302764. J Cardiovasc Pharmacol Ther. 2007. PMID: 17562778 Review.
[Should B-type natriuretic peptide (BNP) be used in daily practice?].
Sarasin FP. Sarasin FP. Rev Med Suisse. 2005 Nov 23;1(42):2726, 2728-30. Rev Med Suisse. 2005. PMID: 16366447 French.
[Usefulness of B-type natriuretic peptide (BNP) for the diagnosis of new-onset heart failure with a preserved left ventricular systolic function in longstanding hypertensive patients with acute dyspnea].
Arquès S, Roux E, Sbragia P, Pieri B, Gélisse R, Luccioni R, Ambrosi P. Arquès S, et al. Arch Mal Coeur Vaiss. 2007 Feb;100(2):113-20. Arch Mal Coeur Vaiss. 2007. PMID: 17474496 Clinical Trial. French.
Biomarkers in heart failure management.
Isaac DL. Isaac DL. Curr Opin Cardiol. 2008 Mar;23(2):127-33. doi: 10.1097/HCO.0b013e3282f43039. Curr Opin Cardiol. 2008. PMID: 18303525 Review.

See all similar articles

Cited by

Biomarkers for the diagnosis and management of heart failure.
Castiglione V, Aimo A, Vergaro G, Saccaro L, Passino C, Emdin M. Castiglione V, et al. Heart Fail Rev. 2022 Mar;27(2):625-643. doi: 10.1007/s10741-021-10105-w. Epub 2021 Apr 14. Heart Fail Rev. 2022. PMID: 33852110 Free PMC article. Review.
NT-proBNP and Echocardiographic Parameters in Liver Cirrhosis - Correlations with Disease Severity.
Mihailovici AR, Donoiu I, Gheonea DI, Mirea O, Târtea GC, Buşe M, Calborean V, Obleagă C, Pădureanu V, Istrătoaie O. Mihailovici AR, et al. Med Princ Pract. 2019 Apr 16;28(5):432-41. doi: 10.1159/000499930. Online ahead of print. Med Princ Pract. 2019. PMID: 30995644 Free PMC article.
Interpretation of B-type natriuretic peptide in cardiac disease and other comorbid conditions.
Burke MA, Cotts WG. Burke MA, et al. Heart Fail Rev. 2007 Mar;12(1):23-36. doi: 10.1007/s10741-007-9002-9. Epub 2007 Mar 8. Heart Fail Rev. 2007. PMID: 17345160 Review.
Natriuretic peptide-guided therapy: further research required for still-unresolved issues.
De Vecchis R, Esposito C, Cantatrione S. De Vecchis R, et al. Herz. 2013 Sep;38(6):618-28. doi: 10.1007/s00059-013-3772-8. Epub 2013 Apr 17. Herz. 2013. PMID: 23588602 Review.
Natriuretic peptides in the diagnosis and management of heart failure.
Felker GM, Petersen JW, Mark DB. Felker GM, et al. CMAJ. 2006 Sep 12;175(6):611-7. doi: 10.1503/cmaj.060236. CMAJ. 2006. PMID: 16966666 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information